| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/11/2006 | EP1614420A2 Treatment of hypertension, angina and other disorders using (-) amlodipine |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1614416A2 Method for treating amyloidosis |
| 01/11/2006 | EP1613632A1 Pyrrolo(1,2-b)pyridazine compounds and their use as crf-1 receptor antagonists |
| 01/11/2006 | EP1613631A1 Pyrrolo 1,2-b pyridazine compounds and their uses |
| 01/11/2006 | EP1613630A1 Pyrrolo'1,2-b!pyridazine compounds and their use as crf1 receptor antagonists |
| 01/11/2006 | EP1613629A1 Substituted 4-amino 1,2,4 triazolo 4,3-a quinoxalines |
| 01/11/2006 | EP1613628A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 01/11/2006 | EP1613618A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA- sb A /sb RECEPTOR COMPLEX |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613596A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 01/11/2006 | EP1613594A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 01/11/2006 | EP1613593A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 01/11/2006 | EP1613590A2 4-(3,4-disubstituted phenyl)-pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
| 01/11/2006 | EP1613571A1 Deuterated catecholamine derivatives and medicaments comprising said compounds |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/11/2006 | EP1613347A2 Humanized antibodies that recognize beta amyloid peptide |
| 01/11/2006 | EP1613341A2 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 01/11/2006 | EP1613329A1 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| 01/11/2006 | EP1613328A1 Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| 01/11/2006 | EP1613325A1 Combinations comprising paroxetine and 2-(s)-(4-fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(r)-(3,5-bis-trifluoro-2-methyl-phenyl)-ethyl]-methyl amide for treatment of depression and/or anxiety |
| 01/11/2006 | EP1613324A2 Methods for the treatment of pain comprising opioid antagonists |
| 01/11/2006 | EP1613312A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA sb A /sb RECEPTOR COMPLEX |
| 01/11/2006 | EP1613307A2 M sb 3 /sb muscarinic acetylcholine receptor antagonists |
| 01/11/2006 | EP1613303A1 Substituted p-diaminobenzene derivatives |
| 01/11/2006 | EP1613297A1 Therapeutic patch with polysiloxane matrix comprising capsaicin |
| 01/11/2006 | EP1613296A2 Methods for treatment of parkinson's disease |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613265A2 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613264A2 Gaucher disease drugs and methods of identifying same |
| 01/11/2006 | EP1613155A2 Treatment of demyelinating conditions |
| 01/11/2006 | EP1534713B1 Alkyl-substituted pyrazolopyrimidines |
| 01/11/2006 | EP1525202B1 Novel 2,5-disubstituted pyrimidine derivatives |
| 01/11/2006 | EP1442036B1 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1370529B1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1165610B1 Peptide useful in treating multiple sclerosis and a pharmaceutical composition comprising the same |
| 01/11/2006 | EP1133459B1 Sertraline hydrochloride form v |
| 01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720248A Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 01/11/2006 | CN1720239A Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide |
| 01/11/2006 | CN1720237A 3h-quinazolin-4-one derivatives |
| 01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
| 01/11/2006 | CN1720225A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 01/11/2006 | CN1720219A Fused bicyclic or tricyclic amino acids |
| 01/11/2006 | CN1720054A Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
| 01/11/2006 | CN1720049A Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 01/11/2006 | CN1720048A Method and compositions for treating anxiety |
| 01/11/2006 | CN1720041A Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720035A Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 01/11/2006 | CN1720031A Propofol-containing fat emulsions |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1720028A Transdermal analgesic systems with reduced abuse potential |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718566A Ferulaic acid and its sodium salt used for preventing and treating senile dementia medicine |
| 01/11/2006 | CN1718227A Traditional Chinese medicine for giving-up drugs, and its prepn. method |
| 01/11/2006 | CN1718203A Medicine for reducing ache of cancer patient |
| 01/11/2006 | CN1718190A Nux vomica alkaloid liposome, and its prepn. method |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235890C Thizaolyl amide derivatives |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235640C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 01/11/2006 | CN1235637C Methods for treating diabetes |
| 01/11/2006 | CN1235633C Medicine for dropping-off drug and its preparation method |
| 01/11/2006 | CN1235612C Capsule for activating meridians and stopping pain and preparing method thereof |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/11/2006 | CN1235574C Use of central China fruit of Chinese magnoliavine ketone in preparing medicine or food for preventing and treating Alzheimer's disease |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984664 Reduce side effect; analgesics |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984632 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
| 01/10/2006 | US6984496 Vitro assay for testing gabapentinoid activity |
| 01/10/2006 | US6984405 Compositions for inducing secretion of insulin-like growth factor-1 |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/10/2006 | CA2373395C Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/10/2006 | CA2198630C Acetaminophen sustained-release formulation |
| 01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |
| 01/05/2006 | WO2006002121A2 Compounds and methods for treating seizure and paroxysmal disorders |
| 01/05/2006 | WO2006000222A2 The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia |
| 01/05/2006 | WO2006000158A1 The use of laetispicine for manufacture of pharmaceutical composition |